DSS and PGN are not the only low molecular weight ( 50,000 Da .) sulfated polysaccharides that result in similar toxicological effects
Specific Considerations for Non-Diabetics While semaglutide is traditionally used for managing type 2 diabetes, its approval for weight loss in non-diabetic patients requires careful consideration of dosage and administration
What is the Best Diet While on Semaglutide
Tirzepatide patients lost an average of 20.2% of their body weight, while semaglutide patients lost 13.7%, a difference of 6.5 percentage points.[1] In practical terms, for someone starting at 250 pounds, that means losing roughly 50 pounds (22.8 kg) on tirzepatide versus 33 pounds (15.0 kg) on semaglutide.[1] Waist circumference shrank by an average of 7.2 inches (18.4 cm) with tirzepatide versus 5.1 inches (13.0 cm) with semaglutide, a difference with real implications for heart disease risk.[1] When researchers looked at more dramatic weight loss thresholds, tirzepatide pulled further ahead
The difference between 37 and 38 units at 20 mg/mL is only 0.2 mg of tirzepatide, a negligible amount that will not affect results
Manias and D
